中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共23条,第1-10条 帮助

条数/页: 排序方式:
A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  
Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S.
  |  收藏  |  浏览/下载:118/0  |  提交时间:2022/12/23
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文  OAI收割
BMC CANCER, 2022, 卷号: 22
作者:  
Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
  |  收藏  |  浏览/下载:85/0  |  提交时间:2022/12/23
The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer 期刊论文  OAI收割
TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10
作者:  
Pan, Guoqiang;  Chen, Kaiyan;  Yu, Xiaoqing;  Sheng, Jiamin;  Fan, Yun
  |  收藏  |  浏览/下载:55/0  |  提交时间:2021/11/01
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文  OAI收割
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  
Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
  |  收藏  |  浏览/下载:103/0  |  提交时间:2020/12/24
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割
MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15
作者:  
Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
  |  收藏  |  浏览/下载:91/0  |  提交时间:2020/07/01
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation 期刊论文  OAI收割
THERANOSTICS, 2020, 卷号: 10, 期号: 14, 页码: 6122-6135
作者:  
Yin, Weimin
  |  收藏  |  浏览/下载:95/0  |  提交时间:2020/07/01
Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFR(T790M)-Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery 期刊论文  OAI收割
SMALL, 2018, 卷号: 14, 期号: 47
作者:  
Yin, Weimin;  Yu, Xiaolu;  Kang, Xuejia;  Zhao, Yuge;  Zhao, Pengfei
  |  收藏  |  浏览/下载:115/0  |  提交时间:2019/01/08
Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 298-306
作者:  
Yan, Qi;  Chen, Yuzhe;  Tang, Baiyou;  Xiao, Qiang;  Qu, Rong
  |  收藏  |  浏览/下载:84/0  |  提交时间:2019/01/08
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo 期刊论文  OAI收割
CANCER MEDICINE, 2018, 卷号: 7, 期号: 4, 页码: 1430-1439
作者:  
Zhang, Zhang;  Zou, Jian;  Yu, Lei;  Luo, Jinfeng;  Li, Yan
  |  收藏  |  浏览/下载:79/0  |  提交时间:2019/01/08
Synthesis and Biological Activities of Novel 2-Aminobenzimidazoles EGFR~(T790M) Inhibitors 期刊论文  OAI收割
Chinese Journal of Synthetic Chemistry, 2018, 卷号: 26, 期号: 9, 页码: 637-646
作者:  
Duan Jingyi;  Zhang Yinyong;  Qian Anran;  Tong Linjiang;  Xie Hua
  |  收藏  |  浏览/下载:39/0  |  提交时间:2019/01/08